The Efficacy of PX0612 In The Treatment Of Irritable Bowel Syndrome

clinical trial

The Efficacy of PX0612 In The Treatment Of Irritable Bowel Syndrome is …
instance of (P31):
clinical trialQ30612

External links are
P3098ClinicalTrials.gov IDNCT02431533

P6099clinical trial phasephase II clinical trialQ42824440
P17countryCanadaQ16
P582end time2017-06-01
P4135maximum age65
P1050medical conditiondiarrheaQ40878
syndromeQ179630
irritable bowel syndromeQ838966
P2899minimum age18
P1132number of participants94
P4844research interventioncalcium oxalateQ412399
P580start time2016-01-01
P8363study typeinterventional studyQ78089383
P1476titleThe Efficacy of PX0612 In The Treatment Of Irritable Bowel Syndrome: A Randomized, Double-Blind Placebo Controlled Clinical Trial